Literature DB >> 19269017

p16, Ki-67, and BD ProExC immunostaining: a practical approach for diagnosis of cervical intraepithelial neoplasia.

Ann E Walts1, Shikha Bose.   

Abstract

p16, Ki-67, and BD ProExC (TriPath Imaging, Inc., Burlington, NC) have each been shown to be helpful adjuncts in the diagnosis and grading of human papillomavirus-associated cervical intraepithelial neoplasia. However, no clear guidelines are available regarding their use in routine practice. This study was designed to evaluate the efficacy of the 3 stains alone and in combinations to determine the most useful strategy in the diagnosis of cervical intraepithelial neoplasia and provide guidance in instances with discordant staining patterns. Serial sections of 136 formalin-fixed paraffin-embedded cervical samples with consensus diagnoses of 39 benign-reactive, 46 low-grade cervical intraepithelial neoplasia (CIN I/human papillomavirus), and 51 high-grade cervical intraepithelial neoplasia (CINII/III) were immunostained using p16, Ki-67, and BD ProExC antibodies. Results of high-risk human papillomavirus testing were available in 70 cases. Immunostaining patterns were designated as negative, intermediate, and strongly positive based on the patterns observed most commonly in benign-reactive, low-grade cervical intraepithelial neoplasia, and high-grade cervical intraepithelial neoplasia lesions, respectively. A concordant staining pattern with all 3 stains correctly identified benign-reactive, low-grade cervical intraepithelial neoplasia, and high-grade cervical intraepithelial neoplasia cases. p16 was the most sensitive and specific individual stain (sensitivity, 33%; specificity, 93%; positive predictive value [PPV], 81%; negative predictive value [NPV], 58%). Performing all 3 immunostains and using concordant results of any 2 improved diagnostic accuracy (sensitivity, 35%; specificity, 98%; PPV, 93%; NPV, 67%). However, a significant proportion of low-grade cervical intraepithelial neoplasia cases showed aberrant staining patterns with 52% staining negative and 9% staining strongly positive. Low-grade cervical intraepithelial neoplasia cases with the negative staining pattern were more likely to be negative for high-risk human papillomavirus, whereas those showing the strongly positive staining pattern were high-risk human papillomavirus positive. Performing p16 and BD ProExC initially followed by Ki-67 only when p16 and BD ProExC yielded discordant results provided similar diagnostic accuracy at reduced cost because only one third of the cases required the additional stain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19269017     DOI: 10.1016/j.humpath.2008.12.005

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.

Authors:  Christina S Kong; Andrew H Beck; Teri A Longacre
Journal:  Am J Surg Pathol       Date:  2010-07       Impact factor: 6.394

2.  MOLECULAR MARKERS OF EARLY CERVICAL NEOPLASIA.

Authors:  Alvaro P Pinto; Christopher P Crum; Michelle S Hirsch
Journal:  Diagn Histopathol (Oxf)       Date:  2010-10-01

3.  Automated detection of dual p16/Ki67 nuclear immunoreactivity in liquid-based Pap tests for improved cervical cancer risk stratification.

Authors:  Arkadiusz Gertych; Anika O Joseph; Ann E Walts; Shikha Bose
Journal:  Ann Biomed Eng       Date:  2012-01-04       Impact factor: 3.934

Review 4.  [Modern biomarkers for precancerous lesions of the uterine cervix : Histological-cytological correlation and use].

Authors:  D Schmidt
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

5.  Efficacy of p16 and Ki-67 immunostaining in the detection of squamous intraepithelial lesions in a high-risk HPV group.

Authors:  Sharon Lim; Mi Ja Lee; Inju Cho; Ran Hong; Sung Chul Lim
Journal:  Oncol Lett       Date:  2015-12-31       Impact factor: 2.967

6.  Cervical intraepithelial neoplasia in pregnancy: Interference of pregnancy status with p16 and Ki-67 protein expression.

Authors:  Andrea Ciavattini; Francesco Sopracordevole; Jacopo Di Giuseppe; Lorenzo Moriconi; Guendalina Lucarini; Francesca Mancioli; Antonio Zizzi; Gaia Goteri
Journal:  Oncol Lett       Date:  2016-11-29       Impact factor: 2.967

7.  Role of ProEx C immunocytochemistry in cervical high-grade squamous intraepithelial lesions detection.

Authors:  Carmen Ungureanu; Demetra Gabriela Socolov; Gabriela Anton; Eugenia Moroşan; Laura Mihaela Trandafir; Ludmila Lozneanu; Mioara Florentina Trandafirescu; Elena Cojocaru
Journal:  Rom J Morphol Embryol       Date:  2021 Oct-Dec       Impact factor: 0.833

8.  Computerized delineation of nuclei in liquid-based pap smears stained with immunohistochemical biomarkers.

Authors:  Yi Qin; Ann E Walts; Beatrice S Knudsen; Arkadiusz Gertych
Journal:  Cytometry B Clin Cytom       Date:  2014-10-03       Impact factor: 3.058

9.  Evaluation of ProExC as a prognostic marker in oropharyngeal squamous cell carcinomas.

Authors:  Anne M Mills; Andrew H Beck; Nader Pourmand; Quynh Thu Le; Christina S Kong
Journal:  Am J Surg Pathol       Date:  2012-08       Impact factor: 6.394

10.  Risk of progression of early cervical lesions is associated with integration and persistence of HPV-16 and expression of E6, Ki-67, and telomerase.

Authors:  Arianna Vega-Peña; Berenice Illades-Aguiar; Eugenia Flores-Alfaro; Esther López-Bayghen; Marco Antonio Leyva-Vázquez; Eduardo Castañeda-Saucedo; Luz Del Carmen Alarcón-Romero
Journal:  J Cytol       Date:  2013-10       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.